Skip to Main Content
HealthCast Season 2 Episode 30 36m listen

How AI, Data Are Boosting FDA’s Regulatory Processes

A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.

The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.

Related Content
Woman listening to podcast

Stay in the Know

Subscribe now to receive our newsletters